By Regina G. Barber, Anil Oza, Ailsa Chang, Rachel Carlson Neuroscientist Nathan Sawtell has spent a lot of time studying a funky looking electric fish characterized by its long nose. The Gnathonemus petersii, or elephantnose fish, can send and decipher weak electric signals, which Sawtell hopes will help neuroscientists better understand how the brain pieces together information about the outside world. But as Sawtell studied these electric critters, he noticed a pattern he couldn't explain: the fish tend to organize themselves in a particular orientation. "There would be a group of subordinates in a particular configuration at one end of the tank, and then a dominant fish at the other end. The dominant fish would swim in and break up the group, and they would scatter. A few seconds later, the group would coalesce and it would stay there for hours at a time in this stationary configuration," Sawtell, who runs a lab at Columbia University's Zuckerman Institute says. Initially Sawtell and his team couldn't put together why the fish were always hanging out in this configuration. "What could they really be talking to each other about all of this time?" A new study released this week in Nature by Sawtell and colleagues at Columbia University could have one potential answer: the fish are creating an electrical network that is larger than any field an individual fish can muster alone. In this collective field, the whole school of fish get instantaneous information on changes in the water around them, like approaching predators. Rather than being confused by the flurry of electric signals from other fish, "these fish were clever enough to exploit the pulses of group members to sense their environment," Sawtell says. © 2024 npr

Keyword: Pain & Touch
Link ID: 29187 - Posted: 03.09.2024

By Pam Belluck One of the few treatments the Food and Drug Administration has approved for amyotrophic lateral sclerosis has failed a large clinical trial, and its manufacturer said Friday that it was considering whether to withdraw it from the market. The medication, called Relyvrio, was approved less than two years ago, despite questions about its effectiveness in treating the severe neurological disorder. At the time, the F.D.A.’s reviewers had concluded there was not yet sufficient evidence that the medication could help patients live longer or slow the rate at which they lose functions like muscle control, speaking or breathing without assistance. But the agency decided to greenlight the medication instead of waiting two years for results of a large clinical trial, citing data showing the treatment to be safe and the desperation of patients with a disease that often causes death within two to five years. Since then, about 4,000 patients in the United States have received the treatment, a powder that is mixed with water and either drunk or ingested through a feeding tube and carries a list price of $158,000 a year. Now, results of the 48-week trial of 664 patients are in, and they showed that the treatment did not work better than a placebo. “We are surprised and deeply disappointed,” Justin Klee and Joshua Cohen, the co-chief executive officers of Amylyx Pharmaceuticals, the treatment’s manufacturer, said in a statement. They said they would announce their plans for the medication within eight weeks, “which may include voluntarily withdrawing” it from the market. “We will be led in our decisions by two key principles: doing what is right for people living with A.LS., informed by regulatory authorities and the A.L.S. community, and by what the science tells us,” Mr. Klee and Mr. Cohen said. There are only two other approved A.L.S. medications in the United States: riluzole, approved in 1995, which can extend survival by several months, and edaravone, approved in 2017, which can slow progression by about 33 percent. © 2024 The New York Times Company

Keyword: ALS-Lou Gehrig's Disease
Link ID: 29186 - Posted: 03.09.2024

By Daniel Gilbert and David Ovalle The U.S. Food and Drug Administration approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its kind that could dramatically expand the already huge market for the drug. Wegovy, which has the same active ingredient as diabetes drug Ozempic, already had FDA approval to treat patients who are obese or overweight. It has become a cultural sensation and a blockbuster, bringing in billions of dollars in revenue for its manufacturer, Novo Nordisk. “Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight,” John Sharretts, a director in the FDA’s Center for Drug Evaluation and Research, said in a statement Friday. “We recognize how important this moment is for the millions of people who live with excess weight or obesity and known heart disease, and we will continue to advance options that put their needs first,” Doug Langa, head of Novo Nordisk’s North American operations, said in a statement. The FDA’s expansion of Wegovy’s regulatory label comes after a closely watched clinical trial last year found that the drug dramatically reduced the risk of heart problems for overweight people. In a five-year study of more than 17,600 patients, Wegovy cut the risk of strokes, heart attacks and other cardiovascular problems by 20 percent among overweight adults with a history of heart disease. Expanding Wegovy’s regulatory label could also entice more insurers to cover the pricey drug, according to researchers and Wall Street analysts. “The result will pressure insurers and the federal government to cover this medication,” said Harlan Krumholz, a cardiologist at the Yale School of Medicine. “It will be increasingly difficult to deny people access to these medications, as this is not about appearance but concerns health.”

Keyword: Obesity
Link ID: 29185 - Posted: 03.09.2024

By Veronique Greenwood It can be hard to tell, at first, when a cell is on the verge of self-destruction. It appears to be going about its usual business, transcribing genes and making proteins. The powerhouse organelles called mitochondria are dutifully churning out energy. But then a mitochondrion receives a signal, and its typically placid proteins join forces to form a death machine. They slice through the cell with breathtaking thoroughness. In a matter of hours, all that the cell had built lies in ruins. A few bubbles of membrane are all that remains. “It’s really amazing how fast, how organized it is,” said Aurora Nedelcu, an evolutionary biologist at the University of New Brunswick who has studied the process in algae. Apoptosis, as this process is known, seems as unlikely as it is violent. And yet some cells undergo this devastating but predictable series of steps to kill themselves on purpose. When biologists first observed it, they were shocked to find self-induced death among living, striving organisms. And although it turned out that apoptosis is a vital creative force for many multicellular creatures, to a given cell it is utterly ruinous. How could a behavior that results in a cell’s sudden death evolve, let alone persist? The tools for apoptosis, molecular biologists have found, are curiously widespread. And as they have sought to understand its molecular process and origins, they’ve found something even more surprising: Apoptosis can be traced back to ancient forms of programmed cell death undertaken by single-celled organisms — even bacteria — that seem to have evolved it as a social behavior. © 2024 the Simons Foundation.

Keyword: Apoptosis; Development of the Brain
Link ID: 29181 - Posted: 03.07.2024

By Emily Anthes Colombia is a bird watcher’s paradise. Its stunningly diverse ecosystems — which include mountain ranges, mangrove swamps, Caribbean beaches and Amazonian rainforests — are home to more avian species than any other country on Earth. So when Hamish Spencer, an evolutionary biologist at the University of Otago in New Zealand, booked a bird-watching vacation in Colombia, he was hoping to spot some interesting and unusual creatures. He got more than he bargained for. During one outing, in early January 2023, the proprietor of a local farm drew his attention to a green honeycreeper, a small songbird that is common in forests ranging from southern Mexico to Brazil. But this particular green honeycreeper had highly unusual plumage. The left side of its body was covered in shimmering spring-green feathers, the classic coloring for females. Its right side, however, was iridescent blue, the telltale marker of a male. The bird appeared to be a bilateral gynandromorph: female on one side and male on the other. “It was just incredible,” Dr. Spencer said. “We were lucky to see it.” Gynandromorphism has been documented in a variety of birds, as well as insects, crustaceans and other organisms. But it’s a relatively rare and poorly understood phenomenon. The bird Dr. Spencer saw in Colombia is only the second known case of bilateral gynandromorphism in a green honeycreeper — and the first documented in the wild. © 2024 The New York Times Compan

Keyword: Sexual Behavior
Link ID: 29180 - Posted: 03.07.2024

By Andrew Jacobs Ibogaine, a formidable hallucinogen made from the root of a shrub native to Central Africa, is not for the timid. It unleashes a harrowing psychedelic trip that can last more than 24 hours, and the drug can cause sudden cardiac arrest and death. But scientists who have studied ibogaine have reported startling findings. According to a number of small studies, between a third and two-thirds of the people who were addicted to opioids or crack cocaine and were treated with the compound in a therapeutic setting were effectively cured of their habits, many after just a single session. Ibogaine appears to provide two seemingly distinct benefits. It quells the agony of opioid withdrawal and cravings and then gives patients a born-again-style zeal for sobriety. Now, after decades in the shadows, and with opioid overdose deaths exceeding 100,000 a year, ibogaine is drawing a surge of fresh interest from researchers who believe it has the potential to treat opioid use disorder. “It’s not an exaggeration to say that ibogaine saved my life, allowed me to make amends with the people I hurt and helped me learn to love myself again,” said Jessica Blackburn, 37, who is recovering from heroin addiction and has been sober for eight years. “My biggest frustration is that more people don’t have access to it.” That’s because ibogaine is illegal in the United States. Patients have to go abroad for ibogaine therapy, often at unregulated clinics that provide little medical oversight. Kentucky and Ohio are considering proposals to spend millions of dollars of opioid settlement money on clinical trials for ibogaine therapy. And federal drug researchers have signaled a willingness to allow the drug to be studied again — more than 40 years after regulators pulled the plug on research over concerns about the drug’s cardiac risks. © 2024 The New York Times Company

Keyword: Drug Abuse
Link ID: 29179 - Posted: 03.05.2024

By Paula Span Determining whether someone has Alzheimer’s disease usually requires an extended diagnostic process. A doctor takes a patient’s medical history, discusses symptoms, administers verbal and visual cognitive tests. The patient may undergo a PET scan, an M.R.I. or a spinal tap — tests that detect the presence of two proteins in the brain, amyloid plaques and tau tangles, both associated with Alzheimer’s. All of that could change dramatically if new criteria proposed by an Alzheimer’s Association working group are widely adopted. Its final recommendations, expected later this year, will accelerate a shift that is already underway: from defining the disease by symptoms and behavior to defining it purely biologically — with biomarkers, substances in the body that indicate disease. The draft guidelines, Revised Criteria for Diagnosis and Staging of Alzheimer’s Disease, call for a simpler approach. That could mean a blood test to indicate the presence of amyloid. Such tests are already available in some clinics and doctors’ offices. “Someone who has biomarker evidence of amyloid in the brain has the disease, whether they’re symptomatic or not,” said Dr. Clifford R. Jack Jr., the chair of the working group and an Alzheimer’s researcher at the Mayo Clinic. “The pathology exists for years before symptom onset,” he added. “That’s the science. It’s irrefutable.” He and his colleagues on the panel do not recommend testing people who have no symptoms of cognitive decline. But skeptics predict that’s likely to happen nonetheless. If so, a sizable proportion would test positive for amyloid and would therefore be diagnosed with Alzheimer’s. A 2015 Dutch study estimated that more than 10 percent of cognitively normal 50-year-olds would test positive, as would almost 16 percent of 60-year-olds and 23 percent of 70-year-olds. Most of those individuals would never develop dementia. © 2024 The New York Times Company

Keyword: Alzheimers
Link ID: 29177 - Posted: 03.05.2024

By McKenzie Prillaman It’s no secret that global obesity rates have been rising over the past few decades. But a new analysis quantifies the upsurge. More than 1 billion people worldwide were living with obesity as of 2022, researchers report February 29 in the Lancet. That’s about one-eighth of the global population (SN: 11/15/22). For comparison, nearly 800 million people had obesity in 2016, according to the World Health Organization, or WHO. Obesity is “defined by the presence of excess body fat that impairs health,” says obesity expert Arya Sharma of the University of Alberta in Edmonton, Canada, who was not involved in the study. The chronic disease can raise the risk for conditions like heart disease and type 2 diabetes, vulnerability to diseases like COVID-19, and can also limit mobility and negatively affect mental health (SN: 4/22/20). Global health researcher Majid Ezzati and colleagues examined more than 3,600 population-based studies published over the last several decades encompassing 222 million participants across nearly 200 countries and territories. The researchers divided each participant’s reported weight by their height squared to find their body mass index, or BMI. Analyzing the trends suggested that in 2022, almost 900 million adults worldwide had a BMI of 30 or above, classifying them as having obesity. In children and adolescents ages 5 to 19, nearly 160 million were estimated to have the chronic disease, defined as BMI above a certain point on the WHO’s growth reference curves, which account for age and sex. From 1990 to 2022, the prevalence of obesity roughly doubled in women, tripled in men and quadrupled in children and adolescents. At the same time, global rates of those who were underweight fell. “We shouldn’t be thinking about [underweight and obesity] as two separate things, because the transition from one to the other has been very rapid,” says Ezzati, of Imperial College London. © Society for Science & the Public 2000–202

Keyword: Obesity
Link ID: 29174 - Posted: 03.02.2024

Philip Hoare Whales are extraordinarily sensuous creatures. Those blubbery bodies are highly sensitive, and sensitised. At social meetings, pods of sperm, humpback and right whales will roll around one another’s bodies for hours at a time. I’ve seen a group of right whales engaged in foreplay and penetration lasting an entire morning. I have also watched a male-female couple so blissfully conjoined that they appeared unbothered by our little fishing boat as they passed underneath it. And in what may sound like a career of cetacean voyeurism, I have also been caught up in a fast-moving superpod of dusky dolphins continually penetrating each other at speed, regardless of the gender of their partner. That’s why this week’s report of the first scientifically documented male-to-male sexual interactions between two humpback whales off the coast of Hawaii is not surprising. The remarkable image of a two-metre whale penis entering another male “leaves little room for discussion that there is a sexual component to such behaviour”, as one whale scientist, Jeroen Hoekendijk at the Wageningen Marine Research institute in the Netherlands, notes drily. In fact, one of the whales was ailing and there has been speculation that the encounter may not have been consensual or that the healthy whale was actually giving comfort to the other. Whatever the truth, such “flagrant” acts also expose many of our human presumptions about sexuality, gender and identity. Off the north-west Pacific coast of the US, male orcas often leave family pods to rub their erections against each other’s bellies. But females have also reportedly been seen engaging in sexual contact with one another, too. © 2024 Guardian News & Media Limited

Keyword: Sexual Behavior
Link ID: 29173 - Posted: 03.02.2024

By Erica Goode Authors don’t get to choose what’s going on in the world when their books are published. More than a few luckless writers ended up with a publication date of Sept. 11, 2001, or perhaps Nov. 8, 2016, the day Donald Trump was elected. But Charan Ranganath, the author of “Why We Remember: Unlocking Memory’s Power to Hold on to What Matters,”was more fortunate. His book went on sale last month, not long after the Department of Justice released a report describing President Joe Biden as an “elderly man with a poor memory” who, in interviews, was “struggling to remember events,” including the year that his son Beau died. BOOK REVIEW — “Why We Remember: Unlocking Memory’s Power to Hold on to What Matters,” by Charan Ranganath (Doubleday, 304 pages). The special counsel’s report immediately became a topic of intense discussion — disputed by the White House, seized on by many Republicans, analyzed by media commentators, and satirized by late-night television hosts. But for Ranganath, a psychologist and neuroscientist at the University of California, Davis, who for decades has been studying the workings of memory, the report’s release was a stroke of luck. His book, which dispels many widespread but wrongheaded assumptions about memory — including some to which that special counsel Robert K. Hur appears to subscribe — could easily have been written as a corrective response. If Ranganath has a central message, it is that we are far too concerned about forgetting. Memory does not work like a recording device, preserving everything we have heard, seen, said, and done. Not remembering names or exact dates; having no recollection of the details of a conversation; being unable to recall where you left your glasses or your keys; or watching movies you saw in the past as if you are seeing them for the first time — these are not the symptoms of a failing brain.

Keyword: Learning & Memory
Link ID: 29172 - Posted: 03.02.2024

By Erin Garcia de Jesús A genetic parasite may have robbed humans and other apes of their tails. Around 25 million years ago, this parasite, a small stretch of repetitive DNA called an Alu element, ended up in a gene important for tail development, researchers report in the Feb. 29 Nature. The single insertion altered the gene Tbxt in a way that seems to have sparked one of the defining differences between monkeys and apes: Monkeys have tails, apes don’t. “It was like lightning struck once,” says Jef Boeke, a geneticist at New York University Langone Health, and ape behinds ultimately became bare. The genetic tweak may also give insight into why some babies are born with spinal cord defects such as spina bifida, when the tube that holds the cord doesn’t close all the way (SN: 12/6/16). Alu elements are part of a group of genetic parasites known as transposons or jumping genes that can hop across genetic instruction books, inserting themselves into their hosts’ DNA (SN: 5/16/17). Sometimes, when the gene slips itself into a piece of DNA that is passed down to offspring, these insertions become permanent parts of our genetic code. Transposons, including more than 1 million Alu elements, are found throughout our genome, says geneticist and systems biologist Bo Xia of the Broad Institute in Cambridge, Mass. Researchers once thought of transposons as genetic garbage, but some have central roles in evolution. Without transposons, the placenta, immune system and insulation around nerve fibers may not exist (SN: 2/16/24). And humans might still have tails. To find out how apes lost their tails, Xia, then at NYU Langone Health, Boeke and colleagues analyzed 140 genes involved in vertebrate tail development. © Society for Science & the Public 2000–2024.

Keyword: Evolution; Epigenetics
Link ID: 29170 - Posted: 02.29.2024

By Anthony Ham What is the meaning of a cat’s meow that grows louder and louder? Or your pet’s sudden flip from softly purring as you stroke its back to biting your hand? It turns out these misunderstood moments with your cat may be more common than not. A new study by French researchers, published last month in the journal Applied Animal Behaviour Science, found that people were significantly worse at reading the cues of an unhappy cat (nearly one third got it wrong) than those of a contented cat (closer to 10 percent). The study also suggested that a cat’s meows and other vocalizations are greatly misinterpreted and that people should consider both vocal and visual cues to try to determine what’s going on with their pets. The researchers drew these findings from the answers of 630 online participants; respondents were volunteers recruited through advertisements on social media. Each watched 24 videos of differing cat behaviors. One third depicted only vocal communication, another third just visual cues, and the remainder involved both. “Some studies have focused on how humans understand cat vocalizations,” said Charlotte de Mouzon, lead author of the study and a cat behavior expert at the Université Paris Nanterre. “Other studies studied how people understand cats’ visual cues. But studying both has never before been studied in human-cat communication.” Cats display a wide range of visual signals: tails swishing side to side, or raised high in the air; rubbing and curling around our legs; crouching; flattening ears or widening eyes. Their vocals can range from seductive to threatening: meowing, purring, growling, hissing and caterwauling. At last count, kittens were known to use nine different forms of vocalization, while adult cats uttered 16. That we could better understand what a cat wants by using visual and vocal cues may seem obvious. But we know far less than we think we do. © 2024 The New York Times Compan

Keyword: Animal Communication; Evolution
Link ID: 29169 - Posted: 02.29.2024

By Benjamin Ryan People who frequently smoke marijuana have a higher risk of heart attack and stroke, according to a study published on Wednesday. The article, published in The Journal of the American Heart Association, is an analysis of responses to the U.S. government’s annual survey on behavioral risk from 2016 to 2020. The respondents answered health questions, including reporting their own health problems related to heart disease. About 4 percent of the respondents reported daily marijuana use, which the researchers suggested raised the chance of a heart attack by 25 percent and of a stroke by 42 percent. Among those who never smoked tobacco, daily use was tied to a 49 percent higher risk of heart attack and a more than doubled risk of stroke, the study indicated. About three-quarters of the respondents said that smoking was their main method of using weed. The other quarter consumed it by vaping, through edibles or drinking it. “Cannabis smoke releases the same toxins and particulate matter that tobacco does,” said the study’s first author, Abra M. Jeffers, a data analyst at Massachusetts General Hospital in Boston. She conducted the analysis during her post-doctoral fellowship at the University of California, San Francisco. The study is merely observational in its review of survey responses; it does not provide conclusive evidence that regular marijuana use causes heart disease. Even so, researchers and experts said they were concerned about its implications, especially as cannabis use has increased in recent years. Thirty-eight states have legalized medical use of marijuana, and 24 have begun allowing recreational use. © 2024 The New York Times Company

Keyword: Drug Abuse
Link ID: 29168 - Posted: 02.29.2024

Ayana Archie The monthly rate of antidepressants being dispensed to young people increased about 64% more quickly during the coronavirus pandemic, according to a study published Monday in the journal Pediatrics. Researchers used the IQVIA Longitudinal Prescription Database to examine a sample of about 221 million prescriptions written for millions of Americans between the ages 12 to 25, and from 2016 to 2022. Researchers additionally separated the data into before and after March 2020, when the pandemic started. The increase was prominent among young women and girls. The monthly rate increased about 130% faster among 12- to 17-year-old girls, and about 57% faster among young women between the ages of 18 and 25. The study hypothesizes this jump could be due to high rates of depression or anxiety, better access to health care, due to things such as telehealth, or people's reliance on prescriptions because of long waitlists for therapy during the pandemic. The dataset includes prescriptions dispensed from "retail, mail-order, and long-term care pharmacies in the United States," the study says, not exclusive health care systems, such as Kaiser Permanente. Conversely, during the pandemic, the monthly antidepressant dispensing rate decreased for boys between the ages of 12 to 17 and did not change for young men between 18 and 25. Though, data shows more male adolescents were sent to the emergency room for suspected suicide attempts in early 2021, compared to early 2019. Between 2019 and 2021, male high school students also reported constantly feeling sad or hopeless more often, according to the researchers. © 2024 npr

Keyword: Depression
Link ID: 29164 - Posted: 02.27.2024

By Annie Melchor When the first known flying dinosaurs took to the skies some 150 million years ago, the evolutionary leap relied on adaptations to their nervous system. The changes remained a mystery, though, because of the paucity of fossilized neural tissue. Now fresh clues have emerged from a study that started with the long-gone dinosaurs’ living kin: the common pigeon, Columba livia. Flight taps neural pathways involving the pigeon’s cerebellum, the new works shows, which prompted study investigator Amy Balanoff and her team to look specifically at that structure in digital brain “endocasts,” created by CT scanning fossilized dinosaur skulls. “The birds can help us look for certain things within these extinct animals,” says Balanoff, assistant professor of evolutionary biology at Johns Hopkins University. “Then these extinct animals can tell us about the evolutionary history leading up to living birds.” An analysis of the endocasts — from 10 dinosaur specimens dating to between 90 and 150 million years ago — revealed that the volume of the cerebellum expanded in birds’ closest relatives, but not in more distant ones. And at some point, the cerebellum began folding — instead of growing — to accommodate more neurons within a fixed cranial space, Balanoff says. The results suggest that the cerebellum was “flight-ready before flying,” says Crístian Gutiérrez-Ibáñez, an evolutionary biology research associate at the University of Alberta who was not involved in the study. “So the question is, why did dinosaurs get such a big cerebellum?” © 2024 Simons Foundation

Keyword: Evolution; Movement Disorders
Link ID: 29162 - Posted: 02.25.2024

By David Ovalle Keifer Geers was born with a hole in his diaphragm that led to painful surgeries in adulthood. Despite physical challenges that included deafness, Geers graduated from Texas A&M University with a degree in biomedical engineering. He hoped to one day create medical devices for disabled children and wounded veterans. On a spring day as Geers walked with his mother through an airport in Midland, Tex., he stumbled, then collapsed into a seizure, his face contorted in shock. Geers, 33, was pronounced dead at a hospital. His mother later found inside his suitcase several packages of powder kratom, an herbal product he consumed to manage pain from surgeries. Patricia Geers said she was stunned when an autopsy concluded that her son died from the toxic effects of kratom — levels in his blood were more than nine times what some experts believe can prove lethal. The death of Keifer Geers was hardly an isolated episode. A Washington Post review of federal and state statistics shows that medical examiners and coroners are increasingly blaming deaths on kratom — it was listed as contributing to or causing at least 4,100 deaths in 44 states and D.C. between 2020 and 2022. The vast majority of those cases involved other drugs in addition to kratom, which is made from the leaves of tropical trees. Still, the kratom-involved deaths account for a small fraction of the more than 300,000 U.S. overdose deaths recorded in those three years. Dozens of wrongful death lawsuits involving kratom have been filed nationwide — including by Geers’s mother, who in February sued a Nevada retailer. The suits illustrate increased scrutiny of deaths involving products made from kratom, which is banned in six states but remains widely available online and in vape and convenience stores despite health warnings from federal authorities.

Keyword: Drug Abuse
Link ID: 29155 - Posted: 02.22.2024

By Christine Dell'Amore Thunderclouds rolled across Kenya’s Masai Mara savanna as the spotted hyena cubs played, tumbling over each other in the wet grass. The cubs’ mother lounged nearby, rising occasionally to discourage a bigger one-year-old from joining the little play group. When the older animal approached again, one of the pluckier cubs took a cue from its high-ranking mom and stood tall, trying its best to look intimidating. That action seemed comical, but both animals knew their place. The larger, lower ranking hyena stopped short, then bowed its head and slunk off. Photographer Jen Guyton recorded this scene with an infrared camera, allowing an intimate look into hyenas’ nocturnal behaviors. In doing so, she provided a small window into the intriguing structure of hyena society, where all members inherit their place in the pecking order from their mother. Females are in charge, and rank means everything—a matrilineal system that has fueled the spotted hyena’s rise as the most abundant large carnivore in Africa. These and other insights into hyena behavior wouldn’t be possible were it not for 35 years of on-the-ground research by Kay Holekamp, founder of the Mara Hyena Project. Her efforts have helped reveal a creature noted for its advanced society, cognition, and ability to adjust to new surroundings. Holekamp, a biologist at Michigan State University, has been studying the African species in the Masai Mara since 1988—one of the longest running investigations of any mammal ever. “I thought I’d be there for two years,” she says, “but I got hooked.” Hooked on hyenas? Mention their name, and most people grimace. Aristotle described them as “exceedingly fond of putrefied flesh.” Theodore Roosevelt called them a “singular mixture of abject cowardice and the utmost ferocity.” Across Africa, hyenas are seen as evil, greedy, and associated with witchcraft and sexual deviance. Even the 1994 movie The Lion King portrayed them as cunning and malicious. © 1996-2015 National Geographic Society

Keyword: Sexual Behavior; Evolution
Link ID: 29149 - Posted: 02.13.2024

By Miryam Naddaf An analysis of around 1,500 blood proteins has identified biomarkers that can be used to predict the risk of developing dementia up to 15 years before diagnosis. The findings, reported today in Nature Aging1, are a step towards a tool that scientists have been in search of for decades: blood tests that can detect Alzheimer’s disease and other forms of dementia at a very early, pre-symptomatic stage. Researchers screened blood samples from more than 50,000 healthy adults in the UK Biobank, 1,417 of whom developed dementia in a 14-year period. They found that high blood levels of four proteins — GFAP, NEFL, GDF15 and LTBP2 — were strongly associated with dementia. “Studies such as this are required if we are to intervene with disease-modifying therapies at the very earliest stage of dementia,” said Amanda Heslegrave, a neuroscientist at University College London, in a statement to the Science Media Centre in London. According to the World Health Organization, more than 55 million people worldwide currently live with dementia. People are often diagnosed only when they notice memory problems or other symptoms. At that point, the disease might have been progressing for years. “Once we diagnose it, it’s almost too late,” says study co-author Jian-Feng Feng, a computational biologist at Fudan University in Shanghai, China. “And it’s impossible to reverse it.” By screening 1,463 proteins in blood samples from 52,645 people, the authors found that increased levels of GFAP, NEFL, GDF15 and LTBP2 were associated with dementia and Alzheimer’s disease. For some participants who developed dementia, blood levels of these proteins were outside normal ranges more than ten years before symptom onset. © 2024 Springer Nature Limited

Keyword: Alzheimers
Link ID: 29146 - Posted: 02.13.2024

By Simon Makin A new device makes it possible for a person with an amputation to sense temperature with a prosthetic hand. The technology is a step toward prosthetic limbs that restore a full range of senses, improving both their usefulness and acceptance by those who wear them. A team of researchers in Italy and Switzerland attached the device, called ”MiniTouch,” to the prosthetic hand of a 57-year-old man named Fabrizio, who has an above-the-wrist amputation. In tests, the man could identify cold, cool and hot bottles of liquid with perfect accuracy; tell the difference between plastic, glass and copper significantly better than chance; and sort steel blocks by temperature with around 75 percent accuracy, researchers report February 9 in Med. Thank you for being a subscriber to Science News! Interested in more ways to support STEM? Consider making a gift to our nonprofit publisher, Society for Science, an organization dedicated to expanding scientific literacy and ensuring that every young person can strive to become an engineer or scientist. “It’s important to incorporate these technologies in a way that prosthesis users can actually use to perform functional tasks,” says neuroengineer Luke Osborn of Johns Hopkins University Applied Physics Laboratory in Laurel, Md., who was not involved in the study. “Introducing new sensory feedback modalities could help give users more functionality they weren’t able to achieve before.” The device also improved Fabrizio’s ability to tell whether he was touching an artificial or human arm. His accuracy was 80 percent with the device turned on, compared with 60 percent with it off. “It’s not quite as good as with the intact hand, probably because we’re not giving [information about] skin textures,” says neuroengineer Solaiman Shokur of EPFL, the Swiss Federal Institute of Technology in Lausanne. © Society for Science & the Public 2000–2024.

Keyword: Pain & Touch
Link ID: 29144 - Posted: 02.10.2024

By Kristin Kiesel and Richard J. Sexton Many public health advocates and scholars see sugar-sweetened-beverage taxes (often simply called soda taxes) as key to reducing obesity and its adverse health effects. But a careful look at the data challenges this view. We reviewed close to 100 studies that have analyzed current taxes in more than 50 countries and conducted our own research on the effectiveness of soda taxes in the US. There is no conclusive evidence that soda taxes have reduced how much sugar or calories people consume in any meaningful way. Soda taxes alone simply cannot nudge consumers toward healthier food choices. The World Health Organization estimates that more than 17 million people die prematurely each year from chronic noncommunicable diseases. Being overweight or obese is a major risk factor for many of these conditions, including type 2 diabetes, cardiovascular diseases, asthma and several types of cancer. A widely publicized 2019 Lancet Commission report pegged annual obesity-related health-care costs and economic productivity losses at $2 trillion, about 3 percent of the global gross domestic product. Consuming large amounts of added sugars is a key part of this problem. A single 12-ounce can of soda can have more than 10 teaspoons of sugar; drinking just one exceeds the American Heart Association’s recommended daily limits on added sugars. It is easy to see why reducing soda consumption has been a popular target in the war against obesity. One would think that taxing sodas would raise their prices and discourage consumers from purchasing them. With this idea in mind, a wave of taxes has been slapped on sugar-sweetened beverages across the world. For example, cities in California’s Bay Area have imposed a tax of 1 cent per ounce on sugary beverages (a seemingly large price increase given soda’s cost of about 5 cents per ounce in the western US).

Keyword: Obesity
Link ID: 29143 - Posted: 02.10.2024